-
TandemAI Announces the Release of TandemViz™ 1.0 Web-based Graphical User Interface for Seamless Integration of Computational Analyses and Experimental Data
-
TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
-
TandemAI Announces Appointment of Alessandro Monge, Ph.D., as Chief Business Officer
-
TandemAI Announces Appointment of Steve Swann, Ph.D., as Chief Scientific Officer
-
TandemAI Announces Expansion of Senior Leadership Team
-
TandemAI Announces $25 million Seed & Pre-series A Financing led by OrbiMed and Chengwei Capital